Jefferies Group LLC purchased a new position in shares of Phibro Animal Health Corp (NASDAQ:PAHC) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 9,604 shares of the company’s stock, valued at approximately $238,000.
A number of other large investors have also recently modified their holdings of the business. Renaissance Technologies LLC increased its stake in Phibro Animal Health by 5.5% in the fourth quarter. Renaissance Technologies LLC now owns 838,500 shares of the company’s stock valued at $20,820,000 after purchasing an additional 44,000 shares in the last quarter. Raymond James & Associates bought a new stake in Phibro Animal Health in the fourth quarter valued at approximately $1,701,000. Madison Asset Management LLC bought a new stake in Phibro Animal Health in the fourth quarter valued at approximately $3,318,000. Great West Life Assurance Co. Can bought a new stake in Phibro Animal Health in the fourth quarter valued at approximately $627,000. Finally, South Dakota Investment Council increased its stake in Phibro Animal Health by 39.2% in the fourth quarter. South Dakota Investment Council now owns 155,654 shares of the company’s stock valued at $3,865,000 after purchasing an additional 43,842 shares in the last quarter. 52.26% of the stock is owned by hedge funds and other institutional investors.
Shares of PAHC stock opened at $17.87 on Friday. The firm has a fifty day moving average of $25.14 and a 200-day moving average of $23.74. The company has a quick ratio of 1.71, a current ratio of 3.03 and a debt-to-equity ratio of 1.64. Phibro Animal Health Corp has a 12-month low of $16.87 and a 12-month high of $36.98. The company has a market capitalization of $761.73 million, a price-to-earnings ratio of 15.06, a P/E/G ratio of 7.60 and a beta of 0.43.
Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Monday, February 3rd. The company reported $0.34 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.28 by $0.06. Phibro Animal Health had a net margin of 4.67% and a return on equity of 23.94%. The company had revenue of $214.00 million during the quarter, compared to the consensus estimate of $218.87 million. During the same quarter in the prior year, the firm earned $0.41 earnings per share. The firm’s revenue was down 1.9% compared to the same quarter last year. On average, equities analysts expect that Phibro Animal Health Corp will post 1.18 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 25th. Stockholders of record on Wednesday, March 4th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.69%. The ex-dividend date is Tuesday, March 3rd. Phibro Animal Health’s dividend payout ratio is 31.37%.
PAHC has been the subject of several recent analyst reports. Barclays raised shares of Phibro Animal Health from an “underweight” rating to an “equal weight” rating and set a $23.00 target price for the company in a research note on Tuesday, January 28th. G.Research downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 6th. BidaskClub downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Saturday, February 1st. ValuEngine downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, February 4th. Finally, Gabelli downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating and set a $30.00 target price for the company. in a research note on Thursday, February 6th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating and eight have given a hold rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $25.20.
About Phibro Animal Health
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Further Reading: What is cost of equity?
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).
Receive News & Ratings for Phibro Animal Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Phibro Animal Health and related companies with MarketBeat.com’s FREE daily email newsletter.